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Carbon dioxide rebreathing in respiratory protective devices; influence of speech
and work rate in full face masks
Carbon dioxide (CO2) rebreathing has been recognised as a concern regarding respirator use
and is related to symptoms of discomfort, fatigue, dizziness, headache, muscular weakness
and drowsiness. Previous investigations are limited by small sample size and have not
evaluated the relationship between CO2 inhalation and phonic respiration (breathing during
speech) in respiratory protective devices (RPDs). A total of 40 workers trained in the use of
RPDs performed a graded exercise test on a cycle ergonometer that increased in workload
every five minutes. During the third minute of each stage participants read aloud a prepared
text. Measures of mixed expired CO2 (PECO2) mixed inspired CO2 (PICO2), and respiration
were monitored. The results showed phonic respiration and low work rates contributed to
significantly higher levels of CO2 rebreathing. Aiming to reduce CO2 exposure may result in
improved wear time of RPDs. It is recommended that these findings be incorporated in
technical specifications regarding human factors for RPDs.
Practitioner Summary: Carbon dioxide (CO2) rebreathing in respiratory protective devices
(RPDs) has been highlighted as key concern regarding respirator use. However the problem
is relatively under researched. This paper presents novel findings on the impact of phonic
respiration (breathing during speech) and CO2 concentrations in RPDs.

Keywords: carbon dioxide rebreathing; phonic respiration; speech; respiratory
protective devices

1. Introduction
Many researchers have been interested in determining the physiological impact of the use of
respiratory protective devices (RPDs) in human wearers. In recent times carbon dioxide
(CO2) rebreathing in RPDs has been highlighted as a key concern regarding respirator use.
Rebreathing can occur if expired air, which is CO2 rich, remains in the breathing space of the
respirator after each breath. This can increase arterial CO2 concentrations which can generate
symptoms of discomfort, fatigue, dizziness, headache, shortness of breath, muscular
weakness and drowsiness (Kloos and Lamonica 1966).
It is known that dead space (respirator volume) and hypoventilation related to
breathing resistance in RPDs can contribute to CO2 rebreathing. The effects of exercise,
duration of respirator use, breathing technique, individual sensitivity to CO2 and susceptibility
to claustrophobia can also influence CO2 rebreathing (ISO/TS 16976-3: 2011).
The impact of phonic respiration, or breathing during speech, on CO2 levels in RPDs
has not previously been evaluated. Phonic respiration occurs during exhalation and as a
result decreases inhalation time (ISO/TS 16976-1: 2007). According to Boron and Boulpaep
(2005) following the cessation of speech, breathing rate can increase by 25% and alveolar
CO2 (PACO2) falls. Doust and Patrick (1981) proposed that hypercapnia could explain the
above increase in respiration observed at the end of speech. To our knowledge no researchers
have focused on the influence of speech on CO2 concentrations in RPDs.
Therefore, the present study aimed to evaluate if speech and exercise workload had an
impact on CO2 levels in RPDs. In addition the CO2 values will be compared to current
respirator design standards. It was anticipated that speech, gender, body size and workload
(exercise intensity) would influence CO2 concentrations within RPDs. This research will lead
to a better understanding of the physiological response to respirator use.

The study was conducted in two parts: a pilot study conducted at the University of
Wollongong and a field study carried out at a refinery in Mount Isa, Queensland. This report
outlines the results of the field study.

2. Methods
2.1.

Participants

The study was approved by the Human Research Ethics Committee of the University of
Wollongong/South Eastern Sydney and Illawarra Area Health Service (Reference Number:
HE11/437).

A total of 46 participants (one female) familiar with the use of RPDs,

volunteered for the field study. Before taking part, all details of the study were explained and
informed written consent was obtained from participants.
Prior to participation, participants completed a Physical Activity Readiness
Questionnaire (PAR-Q) which is a self administered survey that screens individual’s
cardiovascular disease risk factors and symptoms (PAR-Q 2002). The State-Trait Anxiety
Inventory (STAI) that assesses participants “state” and “trait” anxiety symptoms (Spielberger
et al. 1983) was also administered. Participants were excluded if pregnant, suffering from
severe illness or injury, obtained an STAI score at the ninetieth percentile or above, reported
problems with claustrophobia or unable to obtain a satisfactory face fit with the RPD. In
addition participants were required to be clean shaven, avoid exercise and smoking cigarettes
or cigars on the day of testing.
Of this sample six participants did not meet the selection criteria for inclusion into the
study, leaving a total of 40 participants (one female). The ages ranged from 19 to 58, with a
mean age of 35 (SE = ±1.50). The majority of these participants were non-smokers (n=32)
and 55% (n=22) reported that they were physically active or exercised on a regular basis.

Information on the participants characteristics are provided in Table 1.

2.2.

Equipment

A quantitative respirator fit test with a calibrated TSI Portacount Plus (TSI Incorporated;
Shoreview, MN, USA) was performed to ensure that the RPD achieved an adequate face seal
on the wearer. The TSI Portacount Plus uses a technique known as condensation nuclei
counting (CNC) (TSI 2012). This involves the measurement of the particle concentrations
outside the mask and inside the mask. The ratio of these two values is the RPD fit factor.
Participants were required to obtain an overall fit factor of greater than 500 to be included in
the study. This constraint was important to ensure leakage factors would not limit the results.
The TSI Portacount was pre-programmed with eight sixty second exercises contained in the
Occupational Safety and Health Administration (OSHA) regulations regarding quantitative fit
testing protocols for RPDs (OSHA 2011). This included the following test exercises normal
breathing, deep breathing, turning head side to side, up and down head movement, talking out
loud, grimace (smile or frown), bending over and normal breathing.
A schematic diagram of the apparatus utilised for the exercise test is provided in
Figure 1. The RPD donned was a large full face S.E.A Pty Ltd Respirator with side-mounted
filter (SEA Full Face Mask-SMF-L, The S.E.A Group; Warriewood, New South Wales,
Australia). The RPD was fitted with a Sundstrom SR P510-310 P3 particle filter on one side
and a modular test adaptor on the other. The full face RPD was worn as shown in Figure 2.
The modular test adaptor consisted of a pressure probe which monitored inhalation
and exhalation pressures. This was attached to a Validyne Pressure Transducer (Model
P55D, Validyne Engineering Corporation; Northridge, California, USA). To allow for the
measurement of peak inspiratory air flow (PIAF) the probe was designed to measure pressure
drop in combination with the standard Sundstrom SR 510 P3 particulate filter (accuracy
±0.25% FS). The Validyne Pressure Transducer was calibrated before the assessment dates.

Two gas sampling lines were also installed in the modular test adaptor. The two gas
sampling lines consisted of pneumatic valves (V1, V2). V1 and V2 (see Figure 1) were
controlled to operate as one way valves and collected inspired and expired gas samples within
the oronasal cup.

The two sampling lines were connected externally to inhalation and

exhalation accumulators.

Downstream valves (V3, V4) opened one at a time, thereby

isolating expired and inspired air samples during measurement. A shut off valve (V5) was
used to purge the system before sampling began.
Analysis of CO2 concentration in mixed expired and mixed inspired air samples was
measured via an O2 and CO2 analyser (O2Cap, Oxigraph; Mountain View, USA) single
channel (5-100% O2; 0-10% CO2 range). The analyser obtained air samples with a flow rate
of 250 mL·min-1. The unit was calibrated at regular intervals during test procedures using
certified calibration gas bottles (0% CO2 and 5% CO2). A Data Acquisition (DAQ) system
was connected to a personal computer (PC) and collected data with 50 samples per second
rate. The DAQ system performed data monitoring (such as pressure/ flow, valve control and
CO2 management) and data storage for further analysis.
The exercise test was performed on a stationary cycle ergonometer (Monark
Bodyguard AB; Varberg, Sweden).

The cycle ergonometer was calibrated before the

assessment dates. Participants heart rate was measured throughout the exercise test using a
Polar heart rate monitor (Polar FT1, Polar Electro; Kempele, Finland). The Modified Borg
Scale (MBS) was used to measure participant’s subjective level of dyspnoea (breathing
discomfort). The MBS is a visual analogue scale which allows participants to rate their level
of breathlessness from 0 (Nothing at all) to 10 (Maximal) accessed from the Australian Lung
Foundation (2011). Scores of seven or greater (very severe) were considered termination
criteria for the assessment.

The recorded outcome parameters included percentage of mixed inspired CO2
(PICO2), percentage of mixed expired CO2 (PECO2), heart rate (HR), respiratory frequency
( ), peak inspiratory air flow (PIAF), dyspnoea (MBS) and rate of oxygen uptake ( O2).
O2 was estimated using the leg cycling equation suggested by the American College of
Sports Medicine (ACSM 2006).
O2 (mL·kg-1·min-1) = 1.8 (work rate)/(BM) + Resting O2 ( 3.5 mL·kg-1·min-1) + Unloaded
cycling (3.5 mL·kg-1·min-1)
Where work rate is in kg·m·min-1 and BM is body mass in kg. PIAF,

, PICO2 and PECO2

were calculated by averaging the data during 30 seconds of each measurement period (speech
and no speech).

The variables presented in this article were calculated across all six

workloads (rest, 75 W, 100 W, 125 W, 150 W and 175 W) and the two breathing conditions
(speech and no speech). Measurements of flow rates were corrected to body temperature,
pressure and saturated (BTPS).

2.3.

Test procedures

Exercise tests were carried out in an air-conditioned room maintained at an ambient
temperature of 24° C, with an average relative humidity of 40%. Participants completed a
graded exercise test on a cycle ergonometer wearing the full face S.E.A respirator. Ahead of
the exercise test beginning participants sat on the cycle ergonometer for approximately five
minutes while the apparatus was calibrated and resting data was collected. The test began
with a two minute warm up at 50 W and a pedal rate of 60 revolutions per minute (rpm). The
starting workload was 75 W or 100 W depending on the participants body size, gender or
estimated fitness. The exercise protocol required a constant pedal speed of 60 rpm and
increases in workload by 25 W every five minutes or after a steady state HR was reached
(two heart rates within 5 beats·min-1). During the third minute of exercise participants read

from a prepared text. Talking was discouraged during the periods before and after speech.
During minute two (no speech) and minute three (speech) of each stage gas analysis and
measurement of the physiological parameters (HR, MBS, PIAF) was conducted.
All participants could voluntarily halt the assessment process at any time. The test was
terminated after four stages, volitional fatigue, a rating of dyspnoea of seven or greater or
when the participant reached 85% of their age-predicted maximal HR (220-age).
Immediately after exercise all participants were asked if they experienced any symptoms of
CO2 exposure, such as headache, blurred vision or dizziness. Additionally participants were
allowed an active recovery period of two to five minutes (low load pedalling). The same
RPD was used for each procedure. After each test the RPD was thoroughly cleaned and
disinfected.

2.4.

Statistical analysis

The physiological data were calculated for both breathing conditions (speech and no speech)
across six workloads (Rest, 75 W, 100 W, 125 W, 150 W and 175 W). The effects of
speaking and non speaking conditions on differences in PICO2 and PIAF at each workload
were analysed using multiple paired sample t-tests.

Linear mixed model analysis with

Bonferroni test for post-hoc analysis was conducted to determine the significance of the
effects of

O2 and the experimental conditions, speech and no speech, on PICO2.

A

significance level of p< 0.05 (two tailed) was used for all statistical analysis. All analyses
were completed using Statistical Package for the Social Sciences (SPSS) version 19.

3. Results
Of the 46 volunteers, 13% (n=6) did not meet the selection criteria for inclusion into the
study. Five participants were excluded from participation at the level of the PAR-Q form and

one due to equipment failure. All participants passed a quantitative respirator fit test (>500
protection factor) with a Portacount. Data for the remaining 40 participants who completed
all phases of the test are presented in Table 2.
The duration of the exercise test, including warm up varied from 8-22 minutes. Within
this, 12 participants (30%) did not reach 85% of their age-predicted maximal HR. Reasons to
stop the exercise test before target HR was reached included lower limb fatigue (n=6), end of
exercise protocol (n=3), severe breathing discomfort or dyspnoea (n=2) and general fatigue
(n=1).

3.1.

Speech (phonic respiration)

The mean PICO2 values that occurred during periods of speech and no speech for both rest
and exercise are shown in Table 3. Paired t tests were carried out to compare differences in
PICO2 between the two conditions. A significant difference in PICO2 between periods of
speech and no speech occurred at rest, 75 W, 100 W, 125 W and 150 W. Although there was
a relationship at 175 W, it did not achieve significance.
In general PICO2 levels were below 2% in periods without speech. However during
speech, PICO2 was observed to often exceed this, above all at rest. An elevation of PICO2
above 3% (100 times atmospheric concentrations) was experienced by three participants at
rest (speech). One in three participants (n=11) were exposed to PICO2 greater than 2%
during periods of work and speech (75 W, 100 W and 125 W). In the absence of speech
PICO2 concentrations were observed to decrease, especially with each increase in workload.
The lowest average PICO2 (0.97%) occurred at a mean O2 of 28.7 mL·kg·min-1, no speech.
No participants reported symptoms of headache, blurred vision or dizziness.

3.2.

Peak inspiratory air flow

The mean PIAF for all workloads during periods of speech and no speech is displayed in
Table 4. A paired samples t test was conducted to compare PIAF and the two breathing
conditions (no speech and speech) across the six exercise workloads (rest, 75 W, 100 W, 125
W, 150 W and 175 W) (alpha was set at 0.05). There was a significant difference in PIAF
between periods of speech and no speech at rest, 75 W, 100 W, 125 W and 175 W. Although
there was a relationship at 150 W, it did not achieve significance.
The highest PIAF scores were seen during speech. The maximum mean PIAF was
323.50 L·min-1 and occurred at 175 W during speech, whereas the lowest mean PIAF was
80.50 L·min-1 occurred at rest and during no speech.

3.3.Oxygen uptake
The mean PICO2 levels as a function of mean O2 during speaking and non speaking periods
is displayed in Figure 3. The highest mean ergonometer power setting equivalent to O2 33.2
mL·kg-1·min-1 gave rise to PICO2 of 1.0% (no speech) and 1.4% (speech). It appears with
increased O2, the RPD is more efficient in the removal of dead space CO2.
Linear mixed model analysis was conducted to assess the effects of

O2 and the

experimental conditions, speech and no speech on PICO2. There were five levels of

O2

corresponding to the following groups: rest (n=40), 75 W (n=19), 100 W (n=40), 125 W
(n=36) and 150 W (n=22). Note that 175 W was not tested due to unsatisfactory sample size.
Statistical significance was set at an alpha level of 0.05.
Without speech, the effect of

O2 on PICO2 was significant, F (1, 4) = 19.8, p=0.00.

Similarly, interactions between speech and O2 had significant effects on PICO2, F (1, 4) =
25.7, p = 0.00. Post-hoc tests were conducted to examine all pairwise contrasts using the
Bonferroni adjustment.

Since this involved five pairwise contrasts for each workload

(excluding 175 W due to small sample size) the critical alpha level to be used for these
contrasts was 1/5 times 0.05, that is, a critical  of 0.2. Of the five contrasts without speech,
level one (rest) differed significantly from all others and level 5 (150 W) differed
significantly from level 1 (rest) and level 3 (100 W). However, level 2 (75 W) did not differ
significantly from 3 (100 W) or 4 (125 W) (p<0.05). Similarly during speech, level one (rest)
differed significantly from all others. Level 3 (100 W) did not differ from level 2 (75 W),
level 4 (125 W) and level 5 (150 W). This reflects that CO2 rebreathing is reduced once a
higher

O2 is obtained with exercise. However the difference between PICO2 vs. small

increments in O2 with exercise is less significant.

3.4.

Effects of mixed expired carbon dioxide

On average PECO2 appeared to be higher during periods without speech. The highest mean
PECO2 was 5.8% and occurred at 75 W (speech) and 100 W (no speech).

However the

lowest mean PECO2 was 2.9% and occurred at rest (speech).

3.5.

Dyspnoea

Dyspnoea (MBS) scores during speech and no speech periods are shown in Table 2. No
dyspnoea was reported during resting conditions. Ratings of dyspnoea was reported to be
somewhat severe (4) or higher by 92% (n=12) of participants at 150 W (speech) and 100%
(n=3) at 175 W (speech). Breathing discomfort was reported to rise during both increases in
exercise effort and periods of speech. Due to the opposing effects of these variables on
PICO2 the relationship between PICO2 and dyspnoea did not produce a significant result in
this study.

3.6.

Heart rate

HR was on average 2.9% higher during speech conditions than no speech at the same

workload. Therefore speech appears to increase the work of breathing (energy expenditure).
This effect appeared to decrease as workload increased (175 W excluded).

3.7.

Breathing frequency

Overall, there was a reduction in mean

during speech. During speech

decreased by

23.5% at rest. However progressive increases in exercise workloads caused participants to
speak fewer words from the text and

gradually increased. Consequently

during speech

and non speech periods at 175 W (peak exercise) was comparable.

4. Discussion
Increased levels of CO2 rebreathing in RPDs can have a profound effect on the respiratory
system and is a concern regarding respirator use (ISO/TS 16976-3: 2011). A literature
review by NIOSH (1976) indicates 1% inspired CO2 is associated with respiratory stimulation
such as increased

, alveolar CO2 and O2. This current study demonstrates that periods of

speech in RPDs cause an increase in inspired CO2 well above the normal concentration found
in atmospheric air (0.03%) (Williams 2010). Almost one in three participants inspired CO2
concentrations 2% or higher during periods of speech at sedentary to low work rates. These
findings suggest prolonged speech can contribute to CO2 surpassing current respirator design
standards that specify inspired CO2 should not exceed 1% for more than one consecutive
minute when testing RPDs (AS/NZS 1716: 2003). This specification is also applied in the
Occupational Safety and Health Standards of OSHA: 1910.134 “Respiratory Protection” and
European Standards: EN 13274-6: 2002 for respirator classification.
Similarly, Roberge et al. (2010) examined the physiological impact of N95 filtering
face piece respirators.

Ten adults (seven women) conducted two 60 minute treadmill

assessments at very low workloads walking at 2.74 km·hr-1 (1.7 miles·hr-1) and 4.02 km·hr-1
(2.5 miles·hr-1) while wearing the RPD. Data collected showed that dead-space CO2 ranged

from 2.5-3.5% CO2 which is significantly above OSHA’s ambient workplace standards.
Roberge et al. (2010) concluded that even though the RPD did not impose any significant
physiological burden on participants, CO2 retention was a possibility due to elevated
transcutaneous CO2 (equivalent to arterial CO2) levels. On a similar note, although no
symptoms of CO2 retention were recorded in this study, the increases in CO2 during speech
were sufficient enough to impact the participant.
There has also been concern that exercise compounds CO2 rebreathing in RPDs due to
increased metabolic CO2 production (Williams 2010). In the current study PICO2 was shown
to be inversely related to exercise. This demonstrated that the large full face S.E.A Pty Ltd
Respirator was efficient in the removal of dead space CO2 at higher work rates. These
findings support research conducted by Kloos and Lamonica (1966) and Luria et al. (2004)
who found low work rates during RPD use was associated with CO2 accumulation. A
previous study by Luria et al. (2004) attributed this to a rise in ventilation and lower dead
space during higher exercise efforts.
We also noted that breathing frequency and positive pressure in the mask decreased
each time speech was added.

This also suggests speech produces a reduction alveolar

respiration without a change in metabolic rate which tends to increase CO2 concentrations in
RPDs (ISO/TS 16976-3:2011).
The International Organization for Standardization (ISO) prepared a technical report
on the effects of hypercapnia and the impact of CO2 concentrations on respirator use (ISO/TC
16976-3.2: 2010). ISO (2010) specified that increased concentrations of CO2 in the breathing
space of a RPD may generate dyspnoea which causes the user to remove the device. ISO
(2010) concluded that aiming to reduce CO2 exposure in the breathing space of a RPD is
important to improve the wear time of RPDs in the workplace. The results of the present
study indicate the impact of speech, low work rates and respirator use needs to be evaluated.

We suggest that the findings in this study be incorporated in technical specifications
regarding human factors for RPDs.
Sensitivity to CO2 is a variable that may have confounded the effects of CO2
rebreathing in the present study. It should be acknowledged that the level of response to CO2
rebreathing varies considerably from person to person. For instance research by Love et al.
(1979) and Takahashi et al. (2000) found when CO2 was added to inspired air all participants
increased their respiration but the degree of this response varied considerably.
There was a small increase in HR noted during speech. These effects demonstrate
that there is an increase in physical exertion during speech and RPD use. Therefore speech
may limit physical performance while wearing RPDs.
In this study, the process of speaking and exercise was enough to cause symptoms of
breathing discomfort. Therefore the present study could not attribute any physiological
symptoms of dyspnoea to CO2 rebreathing.
Also, participants were more likely to pause from speaking at higher workloads due to
the breathing requirements required for exercise. This would improve oxygen delivery to the
participant wearing the RPD and decrease the level of CO2 rebreathing. This can potential
confound the results.
It is also important to note exercise intensities in this study were only set at low to
moderate workloads. Therefore differences in PICO2 during maximal exercise, where CO2
production can exceed 4 L·min-1 (ISO 16976-3: 2010) cannot be compared and limits the
interpretation of these results.
A further limitation of the study was the underrepresentation of women and smallmedium body surface area (BSA) groups. Differences in gender and BSA might influence
CO2 production and sensitivity to CO2 exposure. Future research could overcome this by
analysing women and different BSA groups separately.

5. Conclusion
Overall, the results of the study indicate speech and low work rates significantly increase CO2
rebreathing in RPDs. Based on Australian respirator design standards it is evident speech
could contribute to inspired CO2 exceeding the maximal allowable concentrations in inspired
air. However, the impact of gender and body size on CO2 levels could not be ascertained.
The implication of these findings is that high CO2 concentrations in full face RPDs may be
linked to wearer discomfort and contribute to reduced tolerability and wear time of the
device. Since many occupations require workers to communicate while wearing RPDs these
findings must be taken into consideration. It is recommended that the findings in this study
be considered in the design and use of RPDs.
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Table 1. Characteristics of the field study participants
Median Min
19

Max

Age (years)

34

Weight (kg)

89.5

58.0 128.0

Height (m)

1.77

1.67

1.92

BSA (m2)

2.09

1.67

2.41

State Anxiety Score (%)

27

20

50

Trait Anxiety Score (%)

30.5

20

58

47

Table 2. Effects of speech on respiratory parameters during rest and exercise wearing a full face respiratory protective device
Rest

75 Watts

100 Watts

125 Watts

150 Watt

175 Watts

(n=40)

(n=19)

(n=40)

(n=36)

(n=22)

(n=4)

No Speech

M

Speech

SE

M

No Speech

SE

M

SE

Speech

M

No Speech

SE

M

SE

Speech

M

No Speech

SE

M

SE

Speech

M

No Speech

SE

M

Speech

No Speech

SE

M

SE

M

SE

Speech

M

SE

PICO2
(%)

1.5

0.06

2.1*

0.08

1.2

0.03

1.5*

0.06

1.2

0.04

1.6*

0.06

1.1

0.03

1.5*

0.06

1.0

0.03

1.4*

0.05

1.0

0.04

1.4

0.03

PECO2
(%)

3.9

0.06

3.8

0.07

4.8

0.07

4.7

0.09

4.8

0.08

4.6

0.07

4.8

0.69

4.6

0.08

4.6

0.07

4.4

0.12

4.7

0.05

4.6

0.04

HR
(beat·min-1)

82

1.95

84

2.25

112

2.43

116

2.60

121

2.09

125

2.50

134

2.17

137

2.17

144

1.58

146

1.59

150

1.46

157

1.50

17

0.78

13

0.62

21

0.73

18

0.69

22

0.96

19

0.80

25

0.77

21

0.71

26

0.96

24

0.75

26

0.66

26

0.61

7.0

0

-

-

18.8

0.24

-

-

21.6

0.35

-

-

25.3

0.44

-

-

28.7

0.53

-

-

33.2

0.63

-

-

80.50

2.51

125.75*

4.87

150.00

2.37

225.00*

4.56

172.75

3.24

247.25*

4.30

201.50

3.16

268.75*

4.07

232.25

4.88

305.25

5.62

227.75

5.03

323.50*

7.34

0

0.11

0.5

0.12

1

0.19

2.5

0.23

2

0.18

3

0.15

3

0.17

4

0.17

4

0.21

4.5

0.18

3

0.08

5

0.10

(breaths·min-1)
O2 (mL·kg-1·min-1)
PIAF **
(L·min-1)
MBS
(0-10)

M, Mean, SE, Standard Error of the Mean, PICO2, Percentage of Inspired Carbon Dioxide, PECO2, Percentage of Expired Carbon Dioxide, HR, Heart Rate,
, Breathing Frequency, PIAF, Peak Inspiratory Air Flow , MBS, Modified Borg Dyspnoea Scale, BTPS, Body Temperature & Pressure Saturated. Note.
*=Statistical significance (p≤0.05) from paired samples t-test **PIAF is given in BTPS and rounded to the nearest 0.25.

Table 3. Mean carbon dioxide inspired at rest and exercise for conditions of no speech and
speech
No Speech
Speech
M
SE
M
SE
t
df
Rest
1.5
0.06
2.1*
0.08
7.75
38
75 W
1.2
0.03
1.5*
0.06
6.07
18
100 W
1.2
0.04
1.6*
0.06
6.07
35
125 W
1.1
0.03
1.5*
0.06
6.57
33
150 W
1.0
0.03
1.4*
0.05
4.90
11
175 W
1.0
0.04
1.4
0.03
2.93
3
M, Mean, SE, Standard Error of the Mean. Note. *=Statistical significance (p≤0.05) from paired samples ttest.

Table 4. Mean peak inspiratory air flow at rest and exercise for conditions of no speech and
speech
No Speech
Speech
M
SE
M
SE
t
df
Rest
80.50
2.51
125.75*
4.87
2.85
39
75 W
150.00
2.37
225.00*
4.56
5.27
34
100 W
172.75
3.24
247.25*
4.30
4.14
39
125 W
201.50
3.16
268.75*
4.07
4.47
39
150 W
232.25
4.88
305.25
5.62
2.05
39
175 W
227.75
5.03
323.50*
7.34
1.78
39
M, Mean, SE, Standard Error of the Mean. Note. *=Statistical significance (p≤0.05) from paired samples t-test
.

